Influence of donor-recipient HLA-DR matching on efficacy of anti-CD25 mAb in cardiac transplantation.
Lietz
K
K
Columbia University College of Physicians and Surgeons, New York, New York, USA.
Beniaminovitz
A
A
Burke
E
E
John
R
R
Kocher
A
A
Schuster
M
M
Mancini
D
D
Edwards
N
N
Itescu
S
S
D000208:Acute Disease; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000077561:Daclizumab; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006684:HLA-DR Antigens / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D011446:Prospective Studies
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006684:HLA-DR Antigens; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D000077561:Daclizumab